Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator
- 1 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (14) , 1847-1852
- https://doi.org/10.1161/01.cir.0000031162.80988.2b
Abstract
Background— Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are thought to play critical roles in vascular remodeling after injury, with tPA mediating intravascular clot lysis and uPA modulating cell migration within the vessel wall. In human vascular disease, however, thrombus organization and neointimal formation are closely interrelated processes. This study examines the differential roles of tPA and uPA in these processes in mice. Methods and Results— Carotid artery injury and thrombosis were induced in wild-type (WT), uPA-deficient (uPA −/− ), and tPA-deficient (tPA −/− ) mice with the use of ferric chloride. The expression of uPA and tPA was significantly upregulated in the vessel wall of WT mice 1 week after injury, and compared with WT mice, uPA −/− and tPA −/− mice had lower carotid patency rates after injury. At 3 weeks, only 55% of uPA −/− mouse vessels were patent compared with 81% in tPA −/− mice and 100% in WT mice ( P =0.014). Morphometric analysis of injured arterial segments revealed severe luminal stenosis (62±28%) in uPA −/− mice compared with their tPA −/− (16±12%) and WT (6.3±3.6%, P −/− mice developed a cell-rich multilayered neointima and media, the lumen of uPA −/− vessels remained obstructed with acellular unorganized thrombotic material, and their medial areas did not expand. Conclusions— These results indicate that the roles of uPA and tPA in the arterial response to injury are different and more complex than previously assumed and emphasize the critical role of thrombus organization and resolution in neointimal formation and vascular pathology.Keywords
This publication has 13 references indexed in Scilit:
- Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesityJournal of Clinical Investigation, 2001
- AtherosclerosisCell, 2001
- Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1The American Journal of Pathology, 2001
- Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in MiceThe American Journal of Pathology, 2000
- Atherosclerosis: The emerging role of inflammation and the CD40–CD40 ligand systemProceedings of the National Academy of Sciences, 2000
- Differential Role of Components of the Fibrinolytic System in the Formation and Removal of Thrombus Induced by Endothelial InjuryThrombosis and Haemostasis, 1999
- The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectinNature, 1996
- Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?The Journal of cell biology, 1996
- Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.Journal of Clinical Investigation, 1996
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994